Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 5/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5070121 | 0.95 | SMN1; SMN2 (0.41) | SMN1; SMN2POLBBCHEKDM4ERAB9A | |
| SCHEMBL5137367 | 0.94 | KDM4E (0.37) | SMN1; SMN2BCHEKDM4ECYP1A2CYP2D6 | |
| SCHEMBL5137007 | 0.92 | DRD2 (0.38) | SMN1; SMN2POLBBCHEKDM4EC5AR1 | |
| SCHEMBL5070081 | 0.92 | SMN1; SMN2 (0.36) | SMN1; SMN2BCHEKDM4ECYP1A2CYP2D6 | |
| SCHEMBL5138090 | 0.89 | TP53 (0.40) | SMN1; SMN2BCHEKDM4EC5AR1GAA | |
| SCHEMBL5137330 | 0.89 | BCHE (0.43) | BCHEC5AR1KMT2AMEN1 | |
| SCHEMBL5134803 | 0.89 | BCHE (0.43) | BCHEC5AR1 | |
| SCHEMBL5134688 | 0.88 | TP53 (0.39) | SMN1; SMN2BCHEKDM4EC5AR1GAA | |
| SCHEMBL5136649 | 0.87 | LMNA (0.43) | SMN1; SMN2KDM4EC5AR1GAATP53 | |
| SCHEMBL5136445 | 0.86 | DRD2 (0.38) | SMN1; SMN2BCHEKDM4EC5AR1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |